Join the Multiple Sclerosis group to help and get support from people like you.
Multiple Sclerosis News
Related terms: MS
Neuromodulation Methods Show Comparable Outcomes for Neurogenic Bladder in Women With MS
WEDNESDAY, May 7, 2025 – For female patients with multiple sclerosis (MS), transcutaneous posterior tibial nerve stimulation (TPTNS) and repetitive transcranial magnetic stimulation (rTMS) are...
Experimental Drug Can Slow MS Disability
WEDNESDAY, April 9, 2025 – An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial...
AAN: Tolebrutinib Slows Disability in Nonrelapsing Secondary Progressive MS
WEDNESDAY, April 9, 2025 – Tolebrutinib, a brain-penetrant and bioactive Bruton tyrosine kinase inhibitor that modulates persistent immune activation within the central nervous system, slows...
Higher Fish Intake Linked to Reduced Risk for MS Disability Worsening
FRIDAY, Feb. 28, 2025 – Higher fish consumption is associated with slower disability progression in multiple sclerosis (MS), according to a study published online Feb. 25 in the Journal of...
MS Patients May Benefit From Eating More Fish
WEDNESDAY, Feb. 26, 2025 – A diet rich in fish might slow the progression of multiple sclerosis in some patients, a new study says. The nutrients found in fish can quell inflammation and protect...
Early Childhood Sun Exposure Linked to Lower Risk for Pediatric MS Relapse
WEDNESDAY, Feb. 12, 2025 – Greater prenatal and early childhood sun exposure is associated with a lower risk for relapse among children with multiple sclerosis (MS), according to a study published...
More Sunshine in Pregnancy, Infancy Could Benefit Kids With MS
THURSDAY, Feb. 13, 2025 – Children who develop multiple sclerosis appear to fare better if they were exposed to safe amounts of summer sunshine as infants, new research shows. If their moms got some...
Multiple Sclerosis May Worsen With Menopause Transition
FRIDAY, Jan. 24, 2025 – The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, according to a study published online Dec. 23 in Neurology....
Pregnancy Increases Mental Health Risk in MS Patients
THURSDAY, Jan. 23, 2025 – Pregnancy increases the risk of mental illness among women with multiple sclerosis (MS). Pregnant MS patients have a higher risk of mental illness both during gestation and...
FDA Medwatch Alert: Drug Safety Communication: Copaxone, Glatopa (glatiramer acetate) - FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis
ISSUE: The FDA is warning about the risk of a rare but serious allergic reaction with the medicine glatiramer acetate (Copaxone, Glatopa), which is used to treat patients with multiple sclerosis...
COVID-19 Doesn't Worsen Multiple Sclerosis, Study Says
FRIDAY, Dec. 27, 2024 – People with multiple sclerosis (MS) have been concerned that a COVID-19 infection could cause the symptoms of their nerve disease to become even worse. But a new study should...
Adverse Outcomes Seen With MS Disease-Modifying Drugs in Pregnancy
THURSDAY, Jan. 2, 2025 – Disease-modifying therapy (DMT) use for multiple sclerosis (MS) in pregnancy is associated with certain adverse outcomes, including small for gestational age, according to a...
Children Have Various Symptoms Within Five Years Before MS Diagnosis
FRIDAY, Dec. 27, 2024 – Children and adolescents with multiple sclerosis (MS) have a range of symptoms, signs, and diagnoses within five years before diagnosis, according to a study published online...
COVID-19 Infection Not Linked to Changes in MS Symptom Severity
THURSDAY, Dec. 26, 2024 – COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disability, according to a study published online Dec. 23 in...
Certain Risk Factors for MS Linked to Pediatric Brain Volume
TUESDAY, Dec. 17, 2024 – Genetic and environmental risk factors for multiple sclerosis (MS) are associated with brain volume in childhood, according to a study published online Dec. 10 in the...
Further information
Related drug support groups
prednisone, methylprednisolone, Medrol, prednisolone, valacyclovir, dexamethasone, Tecfidera, Ocrevus, Gilenya, dimethyl fumarate, Aubagio